esaprazole,
esaprazole monohydrochloride,
hexaprazol,
N-((N-cyclohexylcarbamoyl)methyl)piperazine,
Esaprazole,
64204-55-3,
Exaprazole,
N-Cyclohexyl-2-piperazin-1-yl-acetamide,
hexaprazole,
N-cyclohexyl-2-(piperazin-1-yl)acetamide,
Esaprazole [INN],
Hexaprazol,
N-cyclohexyl-2-piperazin-1-ylacetamide,
Esaprazolum [INN-Latin],
N-Cyclohexyl-1-piperazineacetamide,
Esaprazola [INN-Spanish],
UNII-38QSU0IB5L,
BRN 0785765,
38QSU0IB5L,
C/63,
C12H23N3O,
1-Piperazineacetamide,N-cyclohexyl-,
1-Piperazineacetamide, N-cyclohexyl-,
NCGC00160434-01,
DSSTox_CID_26147,
DSSTox_RID_81379,
DSSTox_GSID_46147,
Esaprazola,
Esaprazolum,
CAS-64204-55-3,
Prazol,
N-cyclohexyl-2-piperazin-1-ylacetamide dihydrochloride,
AC1L2AJJ,
AC1Q5HHF,
AC1Q5NCE,
5-23-02-00264 (Beilstein Handbook Reference),
MLS004754470,
SCHEMBL931007,
CHEMBL1983100,
DTXSID0046147,
CTK5C0914,
RTFADALJKSFJDZ-UHFFFAOYSA-N,
ALBB-013043,
Tox21_111808,
7294AE,
BDBM50435343,
MFCD00865680,
ZINC19737386,
AKOS000209735,
Tox21_111808_1,
MCULE-8782683340,
NE28840,
N-cyclohexyl-2-(1-piperazinyl)acetamide,
NCGC00160434-02,
AS-44244,
C-63,
SMR002529465,
LS-109890,
N-((N-cyclohexylcarbamoyl)methyl)piperazine,
n-(cyclohexyl-2-piperazin-1-yl)-acetamide,
FT-0678584,
EN300-68725,
AE-641/00334033,
AE-641/30178021,
I13-438,
SR-01000883686,
SR-01000883686-1,
1-piperazineacetamide, N-cyclohexyl-, dihydrochloride,
BRD-K92426617-001-01-4,
Z234896745,
CID68835,
AR-1J1859,
C12-H23-N3-O,
Cyclohexyl 1-pyrrolidinecarboximidoate,
T3538,
1-piperazinyl-4-methylenecarbonylcyclohexylamine,
N-Cyclohexyl-2-piperazin-1-yl-acetamide, 98% - 1G 1g,
97217-84-0,